Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review
Author:
Su Xueying1, Lin Yunting1, Liu Li1, Mei Huifen1, Xu Aijing1, Zeng Chunhua1, Sheng Huiying1, Cheng Jing1, Shao Yongxian1, Zheng Ruidan1, Ting Tzer Hwu2, Zhang Wen1, Li Xiuzhen1
Affiliation:
1. Department of Genetics and Endocrinology, Guangzhou Women and Children’s Medical Center , Guangzhou Medical University , Guangzhou , Guangdong , China 2. Department of Pediatrics , Univeristy Putra Malaysia , Serdang , Selangor , Malaysia
Abstract
Abstract
Objectives
Congenital generalized lipodystrophy (CGL) is a group of rare autosomal inherited diseases characterized by a widespread loss of adipose tissue. The main purpose of this study was to evaluate the features of Chinese patients with CGL2.
Methods
Three patients diagnosed with CGL2 from our center were reviewed. Data on clinical features, results of laboratory analyses, and previous treatments were retrospectively collected. This study also reviewed studies that reported patients diagnosed with CGL2 in the last 30 years.
Results
All patients presented a lack of subcutaneous fat, hypertriglyceridemia, reversed triangular faces, acanthosis nigricans, and hepatomegaly within the first six months of life. All three patients developed splenomegaly, and mental retardation in later life. Dietary control dramatically lowered triglyceride levels in all patients. One patient presented with diabetes mellitus at 1 year-old. Although combined therapy with low fat diet and metformin maintained normal levels of blood lipid and glucose, this patient developed hypertrophic cardiomyopathy at the age of three. By a literature review on all Chinese cases with CGL2, it is known that classic manifestations such as hypertriglyceridemia, hepatomegaly and diabetes mellitus can occur shortly after birth, and early diagnosis and treatment can improve quality of life. In this cohort, the most frequent variations are c.782dupG and c.974dup in the BSCL2 gene. However, the same genotype may have different clinical phenotypes in patients with CGL2.
Conclusions
This study not only described the clinical and genetic features of three patients with CGL2 in China, but also reviewed literature about CGL2 around the world.
Funder
National Natural Science Foundation of China
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference29 articles.
1. Garg, A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220–34. https://doi.org/10.1056/nejmra025261. 2. Patni, N, Garg, A. Congenital generalized lipodystrophies-new insights into metabolic dysfunction. Nat Rev Endocrinol 2015;11:522–34. https://doi.org/10.1038/nrendo.2015.123. 3. Vatier, C, Vantyghem, MC, Storey, C, Jeru, I, Christin-Maitre, S, Feve, B, et al.. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases. Curr Med Res Opin 2019;35:543–52. https://doi.org/10.1080/03007995.2018.1533459. 4. Liu, Y, Li, D, Ding, Y, Kang, L, Jin, Y, Song, J, et al.. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants. Eur J Med Genet 2019;62:103542. https://doi.org/10.1016/j.ejmg.2018.09.009. 5. Hsu, RH, Lin, WD, Chao, MC, Hsiao, HP, Wong, SL, Chiu, PC, et al.. Congenital generalized lipodystrophy in Taiwan. J Formos Med Assoc 2019;118:142–7. https://doi.org/10.1016/j.jfma.2018.02.003.
|
|